Ono Pharmaceutical (Japan)

Recent papers from Ono Pharmaceutical (Japan)

1. Effects of ONO-6950, a Novel Dual Cysteinyl Leukotriene 1 and 2 Receptor Antagonist, in a Rat Model of Pulmonary Arterial HypertensionBiological and Pharmaceutical Bulletin · 2026
2. Impact of dementia severity on efficacy of brexpiprazole for agitation in Alzheimer's dementia: A post hoc analysis of a randomized, double-blind, placebo-controlled study in JapanJournal of Alzheimer s Disease · 2026
3. Efficacy and safety of tirabrutinib monotherapy for relapsed/refractory primary CNS lymphoma: PROSPECT phase 2 trialBlood · 2026
4. Evolution of Real-World Treatment Patterns over Time in Patients with HER2-Negative Advanced Gastric Cancer: A Retrospective Database Cohort Study from JapanAdvances in Therapy · 2026
5. Exploring the Therapeutic Impact of Targeting Brk in Epithelial-Derived Cancer CellsBiological and Pharmaceutical Bulletin · 2026
6. Real-world safety and effectiveness of nivolumab in patients with cancer of unknown primary: results from a nationwide post-marketing surveillance in JapanInternational Journal of Clinical Oncology · 2026
7. P1.100. Impact of Immunotherapy Introduction on Real-World Treatment Patterns for Advanced Esophageal Cancer: A Retrospective Database Cohort Study From JapanDiseases of the Esophagus · 2026
8. Highlights from the 17th Japan Bioanalysis Forum SymposiumBioanalysis · 2026
9. ACKR1-expressing venous endothelial cells establish a pro-fibrotic niche in pulmonary fibrosis2026
10. Encorafenib plus binimetinib for BRAF V600-mutated thyroid cancer in Japan: final analysisInternational Journal of Clinical Oncology · 2026
11. Nivolumab plus chemotherapy or ipilimumab versus chemotherapy as first-line treatment for advanced esophageal squamous cell carcinoma: 5-year follow-up results from CheckMate 648Annals of Oncology · 2026
12. Development of a 2D scintillator-based photon-counting CT for small-animal imagingNuclear Instruments and Methods in Physics Research Section A Accelerators Spectrometers Detectors and Associated Equipment · 2026
13. Correction: An observational study of the effectiveness and safety of nivolumab plus chemotherapy for untreated advanced or recurrent gastric cancer in Japanese real-world settings: the G-KNIGHT studyGastric Cancer · 2026
14. Exploratory identification of candidate biomarkers and molecular contributors to paclitaxel-induced peripheral neuropathy in patients with breast cancer through proteomic analysisFrontiers in Pain Research · 2026
15. IGNITE: a phase III study of tirabrutinib versus rituximab and temozolomide combination therapy in relapsed/refractory primary central nervous system lymphomaFuture Oncology · 2026
16. Development and validation of LC–MS-based bioanalytical methods for oligonucleotide therapeutics: points to considerDrug Metabolism and Pharmacokinetics · 2026
17. Impact of gastric mixing and water intake on postprandial pharmacokinetics of orally disintegrating tablets: A PBBM-based studyEuropean Journal of Pharmaceutics and Biopharmaceutics · 2026
18. EP4 Antagonist ONO-4578 Plus Nivolumab and Chemotherapy in HER2-Negative Unresectable Advanced or Recurrent Gastric or Gastroesophageal Junction CancerJournal of Clinical Oncology · 2026
19. In vivo imaging demonstration using a two-dimensional SiPM-based photon-counting CT system: Preliminary resultsNuclear Instruments and Methods in Physics Research Section A Accelerators Spectrometers Detectors and Associated Equipment · 2026
20. Sleep disturbance due to road traffic noise: A socio-acoustic survey using Lnight estimated from noise mapsThe Journal of the Acoustical Society of America · 2025